FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2022140312> ?p ?o ?g. }

• W2022140312 endingPage "e111886" @default.
• W2022140312 startingPage "e111886" @default.
• W2022140312 abstract "Neoadjuvant chemotherapy (NCT) is a standard treatment option for locally advanced breast cancer. However, the lack of an efficient method to predict treatment response and patient prognosis hampers the clinical evaluation of patient eligibility for NCT. An elevated lymphocyte-to-monocyte ratio (LMR) has been reported to be associated with a favorable prognosis for certain hematologic malignancies and for nasopharyngeal carcinoma; however, this association has not been investigated in breast cancer. The purpose of this study was to evaluate whether pre-NCT LMR analysis could predict the prognosis of patients with locally advanced breast cancer.A retrospective cohort of 542 locally advanced breast cancer patients (T3/T4 and/or N2/N3 disease) receiving NCT followed by radical surgery was recruited between May 2002 and August 2011 at the Fudan University Shanghai Cancer Center. Counts for pre-NCT peripheral absolute lymphocytes and monocytes were obtained and used to calculate the LMR.Univariate and multivariate analysis revealed that higher LMR levels (≥4.25) were significantly associated with favorable DFS (P = 0.009 and P = 0.011, respectively). Additionally, univariate analysis revealed that a higher lymphocyte count (≥1.5×109/L) showed borderline significance for improved DFS (P = 0.054), while a lower monocyte count (<0.4×109/L) was associated with a significantly better DFS (P = 0.010).An elevated pre-NCT peripheral LMR level was a significantly favorable factor for locally advanced breast cancer patient prognosis. This easily obtained variable may serve as a valuable marker to predict the outcomes of locally advanced breast cancer." @default.
• W2022140312 created "2016-06-24" @default.
• W2022140312 creator A5000254862 @default.
• W2022140312 creator A5022412860 @default.
• W2022140312 creator A5031724124 @default.
• W2022140312 creator A5034067305 @default.
• W2022140312 creator A5059057094 @default.
• W2022140312 creator A5060052210 @default.
• W2022140312 creator A5067708799 @default.
• W2022140312 creator A5073216396 @default.
• W2022140312 creator A5086533551 @default.
• W2022140312 creator A5087988582 @default.
• W2022140312 creator A5088168485 @default.
• W2022140312 date "2014-11-05" @default.
• W2022140312 modified "2023-10-01" @default.
• W2022140312 title "An Elevated Peripheral Blood Lymphocyte-to-Monocyte Ratio Predicts Favorable Response and Prognosis in Locally Advanced Breast Cancer following Neoadjuvant Chemotherapy" @default.
• W2022140312 cites W1976044621 @default.
• W2022140312 cites W1979379635 @default.
• W2022140312 cites W1987849966 @default.
• W2022140312 cites W2000843012 @default.
• W2022140312 cites W2017381571 @default.
• W2022140312 cites W2018076768 @default.
• W2022140312 cites W2024861438 @default.
• W2022140312 cites W2052261395 @default.
• W2022140312 cites W2053991659 @default.
• W2022140312 cites W2055081634 @default.
• W2022140312 cites W2056666078 @default.
• W2022140312 cites W2064730985 @default.
• W2022140312 cites W2073690254 @default.
• W2022140312 cites W2093424661 @default.
• W2022140312 cites W2094324498 @default.
• W2022140312 cites W2095027899 @default.
• W2022140312 cites W2109218540 @default.
• W2022140312 cites W2126481441 @default.
• W2022140312 cites W2132893003 @default.
• W2022140312 cites W2135227588 @default.
• W2022140312 cites W2139248078 @default.
• W2022140312 cites W2139291585 @default.
• W2022140312 cites W2152677909 @default.
• W2022140312 cites W2156755241 @default.
• W2022140312 cites W2163651437 @default.
• W2022140312 cites W2167805334 @default.
• W2022140312 cites W2168773839 @default.
• W2022140312 cites W2171778498 @default.
• W2022140312 cites W4237101649 @default.
• W2022140312 doi "https://doi.org/10.1371/journal.pone.0111886" @default.
• W2022140312 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/4221197" @default.
• W2022140312 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/25372468" @default.
• W2022140312 hasPublicationYear "2014" @default.
• W2022140312 type Work @default.
• W2022140312 sameAs 2022140312 @default.
• W2022140312 citedByCount "88" @default.
• W2022140312 countsByYear W20221403122015 @default.
• W2022140312 countsByYear W20221403122016 @default.
• W2022140312 countsByYear W20221403122017 @default.
• W2022140312 countsByYear W20221403122018 @default.
• W2022140312 countsByYear W20221403122019 @default.
• W2022140312 countsByYear W20221403122020 @default.
• W2022140312 countsByYear W20221403122021 @default.
• W2022140312 countsByYear W20221403122022 @default.
• W2022140312 countsByYear W20221403122023 @default.
• W2022140312 crossrefType "journal-article" @default.
• W2022140312 hasAuthorship W2022140312A5000254862 @default.
• W2022140312 hasAuthorship W2022140312A5022412860 @default.
• W2022140312 hasAuthorship W2022140312A5031724124 @default.
• W2022140312 hasAuthorship W2022140312A5034067305 @default.
• W2022140312 hasAuthorship W2022140312A5059057094 @default.
• W2022140312 hasAuthorship W2022140312A5060052210 @default.
• W2022140312 hasAuthorship W2022140312A5067708799 @default.
• W2022140312 hasAuthorship W2022140312A5073216396 @default.
• W2022140312 hasAuthorship W2022140312A5086533551 @default.
• W2022140312 hasAuthorship W2022140312A5087988582 @default.
• W2022140312 hasAuthorship W2022140312A5088168485 @default.
• W2022140312 hasBestOaLocation W20221403121 @default.
• W2022140312 hasConcept C121608353 @default.
• W2022140312 hasConcept C126322002 @default.
• W2022140312 hasConcept C143998085 @default.
• W2022140312 hasConcept C144301174 @default.
• W2022140312 hasConcept C167135981 @default.
• W2022140312 hasConcept C2776694085 @default.
• W2022140312 hasConcept C2777761686 @default.
• W2022140312 hasConcept C38180746 @default.
• W2022140312 hasConcept C530470458 @default.
• W2022140312 hasConcept C71924100 @default.
• W2022140312 hasConcept C90924648 @default.
• W2022140312 hasConceptScore W2022140312C121608353 @default.
• W2022140312 hasConceptScore W2022140312C126322002 @default.
• W2022140312 hasConceptScore W2022140312C143998085 @default.
• W2022140312 hasConceptScore W2022140312C144301174 @default.
• W2022140312 hasConceptScore W2022140312C167135981 @default.
• W2022140312 hasConceptScore W2022140312C2776694085 @default.
• W2022140312 hasConceptScore W2022140312C2777761686 @default.
• W2022140312 hasConceptScore W2022140312C38180746 @default.
• W2022140312 hasConceptScore W2022140312C530470458 @default.
• W2022140312 hasConceptScore W2022140312C71924100 @default.
• W2022140312 hasConceptScore W2022140312C90924648 @default.
• W2022140312 hasIssue "11" @default.
• W2022140312 hasLocation W20221403121 @default.

• next